Research Papers

25 of 354 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Feasibility of Single - Encounter Telemedicine Lung Cancer Screening: A Retrospective Cohort Study in an Underserved Po…
Magarinos J; Lutzow L; Dass C; Ma GX; Erkmen CP.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Information Architects: Using Community-Engaged and Qualitative Methods to Design a Technology-Based Nutrition and Canc…
Vilaro MJ; McAlindon K; Mertens G; Ashley T; Zalake M; Cooks EJ; Krieger JL.
Cancer Control (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent S…
Søreide K; Ismail W; Roalsø M; Ghotbi J; Zaharia C.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Advance Care Planning With Black Women with Breast Cancer: A Community Health Worker Model.
Tan MM; Villamar DM; Huard C; Nicholson L; Medina HN; Moreno PI.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Mammographic Density Reduction is Associated to the Prognosis in Asian Breast Cancer Patients Receiving Hormone Therapy.
Shia WC; Lin LS; Wu HK; Chen CJ; Chen DR.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Revi…
Parpinel G; Laudani ME; Piovano E; Zola P; Lecuru F.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer.
Luo X; Shen Y; Huang W; Bao Y; Mo J; Yao L; Yuan L.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Survival Outcomes of Patients with International Federation of Gynecology and Obstetrics Stage IV Ovarian Cancer: Cytor…
Xiao Y; Linghu H.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients.
You JY; Park KH; Lee ES; Kwon Y; Kim KT; Nam S; Kim DH; Bae JW.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Palliative Medicine Referral and End-of-Life Interventions Among Racial and Ethnic Minority Patients With Advanced or R…
Tabuyo-Martin A; Torres-Morales A; Pitteloud MJ; Kshetry A; Oltmann C; Pearson JM; Khawand M; Schlumbrecht MP; Sanchez JC.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Ga-68-Edotreotide Positron Emission Tomography/Computed Tomography Somatostatin Receptors Tumor Volume Predicts Outcome…
Gallicchio R; Giordano A; Milella M; Storto R; Pellegrino T; Nardelli A; Nappi A; Tarricone L; Storto G.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Surgical Treatment of Pancreatic Cancer: Currently Debated Topics on Vascular Resection.
Pedrazzoli S.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Cost-Effectiveness Analysis of CAR T-Cell Therapies vs Antibody Drug Conjugates for Patients with Advanced Multiple Mye…
Kapinos KA; Hu E; Trivedi J; Geethakumari PR; Kansagra A.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Multimorbidity and Complexity Among Patients with Cancer in Ontario: A Retrospective Cohort Study Exploring the Cluster…
Koné AP; Scharf D; Tan A.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Construction and Validation of a Novel Immune-Related Gene Pairs-Based Prognostic Model in Lung Adenocarcinoma.
Liu Y; Zhou J; Wu J; Zhang X; Guo J; Xing Y; Xie J; Bai Y; Hu D.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-F…
Bryant JM; Palm RF; Herrera R; Rubens M; Hoffe SE; Kim DW; Kaiser A; Ucar A; Fleming J; De Zarraga F; Hodul P; Aparo S; Asbun H; Malafa M; Jimenez R; Denbo J; Frakes JM; Chuong MD.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Safety and Efficacy of Mek Inhibitors in the Treatment of Plexiform Neurofibromas: A Retrospective Study.
Cacchione A; Fabozzi F; Carai A; Colafati GS; Baldo GD; Rossi S; Diana M; Megaro G; Milano GM; Macchiaiolo M; Crocoli A; De Ioris MA; Boccuto L; Secco DE; Zama M; Agolini E; Tomà P; Mastronuzzi A.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocar…
Carvalho de Brito AB; Riechelmann RP; Fonseca de Jesus VH.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Pretreatment Serum Lactate Dehydrogenase and Metastases Numbers as Potential Determinants of Anti-PD-1 Therapy Outcome …
Ali WAS; Huang X; Wu Y; Ma Y; Pan H; Liao J; Yang Z; Hong S; Yang Y; Huang Y; Zhao Y; Fang W; Zhao H; Zhang L.
Cancer Control (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
An Improved Nomogram to Reduce False-Positive Biopsy Rates of Breast Imaging Reporting and Data System Ultrasonography …
Hai L; Feng Y; Zhao J; Tang Q; Wang X; Cao X; Xiao C.
Cancer Control (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Perspectives on Self-Sampling for Cancer Screening From Staff at Federally Qualified Health Centers in Rural and Segreg…
Wood J; Stoltzfus KC; Popalis M; Moss JL.
Cancer Control (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Lung Cancer Screening Knowledge in Four Internal Medicine Programs.
Urrutia Argueta S; Basnet N; Abdul-Kafi O; Hanna N.
Cancer Control (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Anti-Tumor Efficacy of Anti-PD-1/PD-L1 Antibodies in Combination With Other Anticancer Drugs in Solid Tumors: A Systema…
Inoue T; Narukawa M.
Cancer Control (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Quality Assessment of Cervical Cytology Practices in Estonia From 2007 to 2018.
Orumaa M; Innos K; Suurna M; Salumäe L; Veerus P.
Cancer Control (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The Long-Term Outcomes of Surgery Versus Endoscopic Treatment in Patients With Siewert Type II T1M0N0 Adenocarcinoma of…
Chen H; Yu X; Yang R; Li S; Zhang G; Si X; Zhou X.
Cancer Control (Unknown)
Published: 2022
3/6 Transparent
Funding Declared